Clinical trial Recruiting at 1 site Observational Ages 18 and up

Measuring nerve responses during facial pain treatment

Official title: Trigeminal Evoked Responses to Improve Rhizotomy

Run by University of Minnesota · NCT05269472 · Data updated 2026-11-12

This study is testing how nerve responses change in people with trigeminal neuralgia before and after a specific pain treatment to better understand the effects of the procedure.

More Trigeminal Neuralgia trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorUniversity of Minnesota
Academic / other
Locations1 site (Minneapolis, Minnesota)
StatusRecruiting
StartedApril 4, 2022
Main results expectedNovember 1, 2027
Study endsNovember 1, 2027
Registry record updatedNovember 5, 2026
Trial IDNCT05269472 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older scheduled for percutaneous rhizotomy due to facial pain from trigeminal neuralgia.

Probably not a fit

Patients with facial pain of unclear origin or those whose rhizotomy procedure has been canceled may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess somatosensory evoked responses in patients undergoing percutaneous rhizotomy for trigeminal neuralgia. The study will measure these responses at two locations: the contralateral scalp using EEG and at the gasserian ganglion with an FDA-approved electrode. By analyzing these responses before and after the rhizotomy procedure, the study seeks to enhance understanding of the electrophysiological changes associated with trigeminal neuralgia treatment.

Why it matters

Potential benefit: If successful, this study could improve the understanding of trigeminal neuralgia treatment and potentially lead to better management strategies for patients.

How similar studies have gone: While this approach is observational and may build on existing knowledge, similar studies have not been widely reported, indicating a novel exploration in this area.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria (TGN):

* Adults of 18 years or older
* Scheduled to undergo percutaneous rhizotomy for facial pain

Exclusion Criteria (TGN):

* Facial pain of unclear origin (i.e. not clearly TGN pain)
* Rhizotomy procedure canceled

Inclusion Criteria (Healthy controls)

* Adults of 18 years or older

Exclusion Criteria (Healthy Controls)

* Diagnosis or history of facial pain such as TMD or TGN
* History of migraine
* History of any functional pain disorder: fibromyalgia, IBS, CRPS
* Recent chronic pain (within last month)
* Unwilling to participate for two hours in lab
* Current acute pain

Where it's running

  • University of Minnesota
    Minneapolis, Minnesota, United States
    Recruiting

Study contacts

  • Principal investigator: David Darrow — University of Minnesota
  • Study coordinator: Matthew Maple
  • Email: maple036@umn.edu
  • Phone: 612-946-1424

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.